We know that we lose fat and muscle when we lose weight. What happens to bone when we lose weight? Does it matter what treatment strategy you use to lose weight? And, does any change in bone with weight loss translate to an increase in fracture risk?

Learn more: https://drsue.ca/2025/01/how-does-weight-loss-affect-bone-health/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

It is often assumed that people with obesity should have stronger bones as they are supporting a higher weight, and thus be at a lower risk of broken bones (fracture). Is this really true?

Learn more: https://drsue.ca/2024/12/how-does-obesity-affect-bone-health-and-fracture-risk/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

A high level press release of the SURMOUNT-5 study shows that more weight loss is seen with Mounjaro/Zepbound than Wegovy. But does this mean that Mounjaro/Zepbound is BETTER?

Learn more: https://drsue.ca/2024/12/mounjaro-zepbound-and-wegovy-face-off-is-one-better-than-the-other/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Yesterday, Health Canada approved semaglutide 2.4mg (Wegovy) to reduce the risk of heart attacks in people with cardiovascular disease and overweight or obesity. This is a landmark moment in Canada. What does it mean for people with overweight or obesity and cardiovascular disease? Find out Dr. Sue's thoughts here!

Learn more: https://drsue.ca/2024/11/health-canada-approves-wegovy-to-reduce-risk-of-heart-attacks/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

What's new in the Diabetes Canada 2024 guideline on how to choose the best medication for diabetes?

Learn more: https://drsue.ca/2024/11/diabetes-canada-2024-pharmacotherapy-guidelines-update-whats-new/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Can tirzepatide (Mounjaro/Zepbound) provide long term weight loss, prevent diabetes, and treat heart failure with preserved ejection fraction? It's been a busy week - find out here!

Learn more: https://drsue.ca/2024/11/3-year-sustained-weight-loss-powerful-prevention-of-diabetes-and-heart-failure-benefit-with-tirzepatide-mounjaro-zepbound/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Knowing what to do to prepare a person using GLP1 based medication for surgeries requiring anesthesia or sedation remains a clinical conundrum. New multisociety clinical practice guidance was just published in an attempt to harmonize recommendations. What does this updated guidance tell us we should do?

Learn more: https://drsue.ca/2024/11/new-guidance-on-what-to-do-with-glp1-medications-before-surgery-or-sedation-whats-clear-and-whats-not/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Obesity-related knee osteoarthritis is caused not only by increased weight stress on the joints, but also by the chronic inflammatory state that is seen in obesity. Can weight management medication reduce pain? Find out about the results of a study of Wegovy in people with obesity and knee osteoarthritis here!

Learn more: https://drsue.ca/2024/11/knee-pain-from-osteoarthritis-can-weight-management-medication-help/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.